RHUMBLINE ADVISERS - BROOKLYN IMMUNOTHERAPEUTICS ownership

Back to all holdings Add to watchlist

BROOKLYN IMMUNOTHERAPEUTICS's ticker is BTX and the CUSIP is 114082100. A total of 45 filers reported holding BROOKLYN IMMUNOTHERAPEUTICS in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Links
Filings
External links
Quarter-by-quarter ownership
RHUMBLINE ADVISERS ownership history of BROOKLYN IMMUNOTHERAPEUTICS
ValueSharesWeighting
Q1 2022$52,000
-29.7%
25,573
+44.6%
0.00%–
Q4 2021$74,000
-55.2%
17,684
-0.2%
0.00%–
Q3 2021$165,000
-37.3%
17,711
+21.1%
0.00%–
Q2 2021$263,000–14,620–0.00%–
 Download
Other shareholders
BROOKLYN IMMUNOTHERAPEUTICS shareholders Q2 2022
NameSharesValueWeighting ↓
AJ WEALTH STRATEGIES, LLC 36,001$00.00%
View complete list of BROOKLYN IMMUNOTHERAPEUTICS shareholders